Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma

Blood

Volumn 98, Issue 4, 2001, Pages 940-944

  Mandigers, Caroline M P W ^a   Meijerink, Jules P P ^a   Mensink, Ewald J B M ^a   Tonnissen, Evelyn L R T M ^a   Hebeda, Konnie M ^a   Bogman, M José J T ^a   Raemaekers, John M M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEATH; DISEASE ACTIVITY; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MAINTENANCE THERAPY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT FAILURE;

EID: 0035883069     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.4.940     Document Type: Article

References (20)

1. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226:1097-1099.
2. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood. 1992;80:879-886.
3. Price CGA, Meerabux J, Murtagh S, et al. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol. 1991;9:1527-1532.
4. Lambrechts AC, Hupkes PE, Dorssers LCJ, Van't Veer MB. Clinical significance of t(14;18)-positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol. 1994;12:1541-1546.
5. Freedman AS, Gribben JG, Neuberg D, et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood. 1996;88:2780-2786.
6. López-Guillermo A, Cabanillas F, McLaughlin, et al. Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series. Ann Oncol. 2000;11:S137-S140.
7. Apostolidis J, Gupta RK, Grenzelias D, et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up. J Clin Oncol. 2000;18:527-536.
8. Mandigers CMPW, Meijerink JPP, Raemaekers JMM, Schaffenberg AVMB, Mensink EJBM. Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18). Lancet. 1998;352:1522-1523.
9. Solal-Céligny P, Lepage E, Brousse N, et al. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. N Engl J Med. 1993;329:1608-1614.
10. Hagenbeek A, Carde P, Meerwaldt JH, et al. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. J Clin Oncol. 1998;16:41-47.
11. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology. 1993;11:1026-1030.
12. Meijerink JPP, Smetsers TFCM, Raemaekers JMM, Bogmah MJJT, De Witte T, Mensink EJBM. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reaction. Br J Haematol. 1993;84:250-256.
13. Meijerink J, Mandigers C, Van de Locht L, Tönnissen E, Goodsaid F, Raemaekers J. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. J Mol Diagn, Part B of Am J Pathol. 2001;3:55-61.
14. Limpens J, De Jong D, Van Krieken JHJM, et al. BCL-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene. 1991;6:2271-2276.
15. Liu Y, Hernandez AM, Shibata D, Cortopassi GA. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A. 1994;91:8910-8914.
16. Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 1995;85:2528-2536.
17. Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, Fitzgibbon J. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol. 2001;19:420-424.
18. Drillenburg P, Pals ST. Cell adhesion receptors in lymphoma dissemination (review). Blood. 2000;95:1900-1910.
19. Meijerink JPP, Goverde GJ, Smetsers TFCM, et al. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation. Ann Oncol. 1994;5:S43-S45.
20. Hirt C, Dölken G. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation for follicular lymphoma. Bone Marrow Transplant. 2000;25:419-426.